Vascular Stent Market Size, Share, and Outlook, H2-2025 Report- By Type (Coronary Stents, Peripheral Stents, EVAR Stent Grafts, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), By Product (Bare-metal Stents, Drug-eluting Stents, Bioabsorbable Stents)
Description
Vascular Stent Market Outlook
The global Vascular Stent Market Size is valued at $12.6 Billion in 2025 and is forecast to reach $20 Billion in 2032 at a CAGR of 6.8%.
The Vascular Stent Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Vascular Stent Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Coronary Stents, Peripheral Stents, EVAR Stent Grafts, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), By Product (Bare-metal Stents, Drug-eluting Stents, Bioabsorbable Stents), By Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), By Material (Metallic Stents, Cobalt Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Others), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Vascular Stent Market Insights, 2025
The vascular stent market is expanding due to rising cardiovascular diseases, minimally invasive interventions, and technological advancements in stent design. Recent developments include drug-eluting stents, bioresorbable stents, and stents with improved flexibility and radiopacity. Companies are focusing on patient-specific stents, enhanced deliverability, and reduced restenosis rates. Growth is driven by the aging population, rising incidence of coronary and peripheral artery diseases, and outpatient procedure adoption. Research emphasizes improved biocompatibility, long-term safety, and enhanced procedural outcomes. Integration with imaging guidance and robotic-assisted placement is an emerging trend. Regulatory approvals and clinical trial data demonstrating efficacy are facilitating adoption. Overall, the market prioritizes innovation, patient outcomes, and procedural efficiency.
Five Trends Shaping the Global Vascular Stent Market in 2025 and Beyond
The global Vascular Stent Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Vascular Stent Industry?
The Vascular Stent Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Vascular Stent Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Vascular Stent Market Segment Insights
The Vascular Stent Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Coronary Stents, Peripheral Stents, EVAR Stent Grafts, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), By Product (Bare-metal Stents, Drug-eluting Stents, Bioabsorbable Stents), By Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), By Material (Metallic Stents, Cobalt Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Others), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Vascular Stent Industry Value Chain
The chapter identifies potential companies and their operations across the global Vascular Stent Industry ecosystem. It assists decision-makers in evaluating global Vascular Stent Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Vascular Stent Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Vascular Stent Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Vascular Stent Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Vascular Stent Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Vascular Stent Market.
Europe Vascular Stent Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Vascular Stent Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Vascular Stent Industry competitiveness. The report analyses the key Vascular Stent Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Vascular Stent Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Vascular Stent Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Vascular Stent Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Vascular Stent Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Vascular Stent Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Vascular Stent Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp, Cook Medical Inc, Cordis Corp, Endologix Inc, EP Medsystems Inc, Fujifilm Corp, General Electric Company, Johnson & Johnson Inc, JOTEC GmbH, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd, Lombard Medical Technologies Inc, Medtronic PLC, Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corp, Nihon Kohden Corp, Osypka AG, Purple Medical Solution Pvt. Ltd, Sahajanand Medical Technologies Pvt. Ltd, Siemens Healthineers AG, Spectranetics Corp, Stentys SA, Stryker Corp, Terumo Corp, Translumina GmbH, W. L. Gore & Associates Inc, ZOLL Medical Corp. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Vascular Stent Market Scope
Leading Segments
By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others
Leading Companies
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corp
Cook Medical Inc
Cordis Corp
Endologix Inc
EP Medsystems Inc
Fujifilm Corp
General Electric Company
Johnson & Johnson Inc
JOTEC GmbH
Koninklijke Philips N.V.
Lepu Medical Technology (Beijing) Co. Ltd
Lombard Medical Technologies Inc
Medtronic PLC
Meril Life Sciences Pvt. Ltd
MicroPort Scientific Corp
Nihon Kohden Corp
Osypka AG
Purple Medical Solution Pvt. Ltd
Sahajanand Medical Technologies Pvt. Ltd
Siemens Healthineers AG
Spectranetics Corp
Stentys SA
Stryker Corp
Terumo Corp
Translumina GmbH
W. L. Gore & Associates Inc
ZOLL Medical Corp
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Vascular Stent Market Size is valued at $12.6 Billion in 2025 and is forecast to reach $20 Billion in 2032 at a CAGR of 6.8%.
The Vascular Stent Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Vascular Stent Market segments across 22 countries from 2021 to 2032. Key segments covered include By Type (Coronary Stents, Peripheral Stents, EVAR Stent Grafts, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), By Product (Bare-metal Stents, Drug-eluting Stents, Bioabsorbable Stents), By Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), By Material (Metallic Stents, Cobalt Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Others), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Vascular Stent Market Insights, 2025
The vascular stent market is expanding due to rising cardiovascular diseases, minimally invasive interventions, and technological advancements in stent design. Recent developments include drug-eluting stents, bioresorbable stents, and stents with improved flexibility and radiopacity. Companies are focusing on patient-specific stents, enhanced deliverability, and reduced restenosis rates. Growth is driven by the aging population, rising incidence of coronary and peripheral artery diseases, and outpatient procedure adoption. Research emphasizes improved biocompatibility, long-term safety, and enhanced procedural outcomes. Integration with imaging guidance and robotic-assisted placement is an emerging trend. Regulatory approvals and clinical trial data demonstrating efficacy are facilitating adoption. Overall, the market prioritizes innovation, patient outcomes, and procedural efficiency.
Five Trends Shaping the Global Vascular Stent Market in 2025 and Beyond
The global Vascular Stent Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Vascular Stent Industry?
The Vascular Stent Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Vascular Stent Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Vascular Stent Market Segment Insights
The Vascular Stent Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Type (Coronary Stents, Peripheral Stents, EVAR Stent Grafts, Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm), By Product (Bare-metal Stents, Drug-eluting Stents, Bioabsorbable Stents), By Mode of Delivery (Balloon-expandable Stents, Self-expanding Stents), By Material (Metallic Stents, Cobalt Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel, Others), By End-User (Hospitals, Cardiac Centers, Ambulatory Surgical Centers, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Vascular Stent Industry Value Chain
The chapter identifies potential companies and their operations across the global Vascular Stent Industry ecosystem. It assists decision-makers in evaluating global Vascular Stent Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Vascular Stent Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Vascular Stent Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Vascular Stent Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Vascular Stent Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Vascular Stent Market.
Europe Vascular Stent Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Vascular Stent Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Vascular Stent Industry competitiveness. The report analyses the key Vascular Stent Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Vascular Stent Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Vascular Stent Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Vascular Stent Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Vascular Stent Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Vascular Stent Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Vascular Stent Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corp, Cook Medical Inc, Cordis Corp, Endologix Inc, EP Medsystems Inc, Fujifilm Corp, General Electric Company, Johnson & Johnson Inc, JOTEC GmbH, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd, Lombard Medical Technologies Inc, Medtronic PLC, Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corp, Nihon Kohden Corp, Osypka AG, Purple Medical Solution Pvt. Ltd, Sahajanand Medical Technologies Pvt. Ltd, Siemens Healthineers AG, Spectranetics Corp, Stentys SA, Stryker Corp, Terumo Corp, Translumina GmbH, W. L. Gore & Associates Inc, ZOLL Medical Corp. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Vascular Stent Market Scope
Leading Segments
By Type
Coronary Stents
Peripheral Stents
EVAR Stent Grafts
Abdominal Aortic Aneurysm
Thoracic Aortic Aneurysm
By Type
Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents
By Mode of Delivery
Balloon-expandable Stents
Self-expanding Stents
By Material
Metallic Stents
Cobalt Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Others
By End-User
Hospitals
Cardiac Centers
Ambulatory Surgical Centers
Others
Leading Companies
Abbott Laboratories
B. Braun Melsungen AG
Biotronik SE & Co. KG
Boston Scientific Corp
Cook Medical Inc
Cordis Corp
Endologix Inc
EP Medsystems Inc
Fujifilm Corp
General Electric Company
Johnson & Johnson Inc
JOTEC GmbH
Koninklijke Philips N.V.
Lepu Medical Technology (Beijing) Co. Ltd
Lombard Medical Technologies Inc
Medtronic PLC
Meril Life Sciences Pvt. Ltd
MicroPort Scientific Corp
Nihon Kohden Corp
Osypka AG
Purple Medical Solution Pvt. Ltd
Sahajanand Medical Technologies Pvt. Ltd
Siemens Healthineers AG
Spectranetics Corp
Stentys SA
Stryker Corp
Terumo Corp
Translumina GmbH
W. L. Gore & Associates Inc
ZOLL Medical Corp
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
195 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Vascular Stent Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Vascular Stent Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Vascular Stent Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Vascular Stent Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Vascular Stent Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Type
- Coronary Stents
- Peripheral Stents
- EVAR Stent Grafts
- Abdominal Aortic Aneurysm
- Thoracic Aortic Aneurysm
- By Type
- Bare-metal Stents
- Drug-eluting Stents
- Bioabsorbable Stents
- By Mode of Delivery
- Balloon-expandable Stents
- Self-expanding Stents
- By Material
- Metallic Stents
- Cobalt Chromium
- Platinum Chromium
- Nickel Titanium
- Stainless Steel
- Others
- By End-User
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
- 6. Global Vascular Stent Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Vascular Stent Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Vascular Stent Market Trends and Growth Opportunities
- 6.2.1 North America Vascular Stent Market Outlook by Type
- 6.2.2 North America Vascular Stent Market Outlook by Application
- 6.3 North America Vascular Stent Market Outlook by Country
- 6.3.1 The US Vascular Stent Market Outlook, 2021- 2032
- 6.3.2 Canada Vascular Stent Market Outlook, 2021- 2032
- 6.3.3 Mexico Vascular Stent Market Outlook, 2021- 2032
- 7. Europe Vascular Stent Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Vascular Stent Market Trends and Growth Opportunities
- 7.2.1 Europe Vascular Stent Market Outlook by Type
- 7.2.2 Europe Vascular Stent Market Outlook by Application
- 7.3 Europe Vascular Stent Market Outlook by Country
- 7.3.2 Germany Vascular Stent Market Outlook, 2021- 2032
- 7.3.3 France Vascular Stent Market Outlook, 2021- 2032
- 7.3.4 The UK Vascular Stent Market Outlook, 2021- 2032
- 7.3.5 Spain Vascular Stent Market Outlook, 2021- 2032
- 7.3.6 Italy Vascular Stent Market Outlook, 2021- 2032
- 7.3.7 Russia Vascular Stent Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Vascular Stent Market Outlook, 2021- 2032
- 8. Asia Pacific Vascular Stent Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Vascular Stent Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Vascular Stent Market Outlook by Type
- 8.2.2 Asia Pacific Vascular Stent Market Outlook by Application
- 8.3 Asia Pacific Vascular Stent Market Outlook by Country
- 8.3.1 China Vascular Stent Market Outlook, 2021- 2032
- 8.3.2 India Vascular Stent Market Outlook, 2021- 2032
- 8.3.3 Japan Vascular Stent Market Outlook, 2021- 2032
- 8.3.4 South Korea Vascular Stent Market Outlook, 2021- 2032
- 8.3.5 Australia Vascular Stent Market Outlook, 2021- 2032
- 8.3.6 South East Asia Vascular Stent Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Vascular Stent Market Outlook, 2021- 2032
- 9. South America Vascular Stent Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Vascular Stent Market Trends and Growth Opportunities
- 9.2.1 South America Vascular Stent Market Outlook by Type
- 9.2.2 South America Vascular Stent Market Outlook by Application
- 9.3 South America Vascular Stent Market Outlook by Country
- 9.3.1 Brazil Vascular Stent Market Outlook, 2021- 2032
- 9.3.2 Argentina Vascular Stent Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Vascular Stent Market Outlook, 2021- 2032
- 10. Middle East and Africa Vascular Stent Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Vascular Stent Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Vascular Stent Market Outlook by Type
- 10.2.2 Middle East and Africa Vascular Stent Market Outlook by Application
- 10.3 Middle East and Africa Vascular Stent Market Outlook by Country
- 10.3.1 Saudi Arabia Vascular Stent Market Outlook, 2021- 2032
- 10.3.2 The UAE Vascular Stent Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Vascular Stent Market Outlook, 2021- 2032
- 10.3.4 South Africa Vascular Stent Market Outlook, 2021- 2032
- 10.3.5 Egypt Vascular Stent Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Vascular Stent Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- B. Braun Melsungen AG
- Biotronik SE & Co. KG
- Boston Scientific Corp
- Cook Medical Inc
- Cordis Corp
- Endologix Inc
- EP Medsystems Inc
- Fujifilm Corp
- General Electric Company
- Johnson & Johnson Inc
- JOTEC GmbH
- Koninklijke Philips N.V.
- Lepu Medical Technology (Beijing) Co. Ltd
- Lombard Medical Technologies Inc
- Medtronic PLC
- Meril Life Sciences Pvt. Ltd
- MicroPort Scientific Corp
- Nihon Kohden Corp
- Osypka AG
- Purple Medical Solution Pvt. Ltd
- Sahajanand Medical Technologies Pvt. Ltd
- Siemens Healthineers AG
- Spectranetics Corp
- Stentys SA
- Stryker Corp
- Terumo Corp
- Translumina GmbH
- W. L. Gore & Associates Inc
- ZOLL Medical Corp
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
